Hydroxyzine Pamoate
- Product NDC
- 70518-1150
- 11-digit product format
- 705181150
- Labeler code
- 70518
- Product ID
- 70518-1150_e3129941-cb98-9ecc-e053-2a95a90a0a7b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA088496
- Marketing category
- ANDA
- Marketing start
- 2018-05-01
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-1150-0 | 70518115000 | 30 CAPSULE in 1 BLISTER PACK (70518-1150-0) | 30 capsule | 2018-05-01 | 0000-00-00 | No | No | Current |
| 70518-1150-1 | 70518115001 | 60 CAPSULE in 1 BLISTER PACK (70518-1150-1) | 60 capsule | 2022-04-11 | 0000-00-00 | No | No | Current |